Predicting survival time in amyotrophic lateral sclerosis (ALS) more accurately is needed to guide clinical care, planning, and research decisions, according to a study published in “Scientific Reports.” While most ALS patients survive about 2-5 years, survival times range from a few months to more than 10 years, making it difficult for clinicians to counsel patients on advance care planning, or to select patients for drug trials. Keep reading to learn how this study developed a model that provides personalized predictions, specific to each patient, rather than telling patients the average survival time of all ALS patients.
Read more here.
